Twist Bioscience to Become Voting Member of Storage Networking Industry Association
April 21 2022 - 7:00AM
Business Wire
Twist Bioscience Corporation (NASDAQ: TWST), a company enabling
customers to succeed through its offering of high-quality synthetic
DNA using its silicon platform, today announced it has joined the
Storage Networking Industry Association (SNIA www.snia.org) as a
voting member. SNIA is a nonprofit organization made up of storage
professionals and is the globally recognized and trusted authority
for storage leadership, standards and technology expertise.
“DNA offers an innovative approach for long-term storage of
data, as it provides a medium for data that will have reading
capabilities in existence for as long as humanity continues to
explore our living environment and the mysteries of our own DNA,”
said Michael Oros, executive director, SNIA. “We believe the
industry as a whole will be eager to explore standards for a new
storage medium that solves the conundrum of having a device in 100
years to read the media archived today.”
“The charter of the SNIA Data Protection and Privacy Committee
(DPPC) is to expand the awareness and adoption of data protection
technology, and to provide education, best practices, and
technology guidance on all matters related to the protection and
privacy of data. We believe DNA provides a long-term data storage
medium for consideration under this charter and welcome Twist
Bioscience as a voting member of SNIA,” commented Pushpendra Kumar
“P.K.” Gupta, co-chair, SNIA DPPC.
“SNIA leads the storage industry in developing and promoting
vendor-neutral architectures, standards and educational services
for storage professionals worldwide,” said Emily M. Leproust,
Ph.D., CEO and co-founder of Twist. “We are committed to actively
participating and engaging with the group as a voting member to
help guide the implementation of new standards for the storage
industry.”
About Twist Bioscience
Twist Bioscience is a leading and rapidly growing synthetic
biology and genomics company that has developed a disruptive DNA
synthesis platform to industrialize the engineering of biology. The
core of the platform is a proprietary technology that pioneers a
new method of manufacturing synthetic DNA by “writing” DNA on a
silicon chip. Twist is leveraging its unique technology to
manufacture a broad range of synthetic DNA-based products,
including synthetic genes, tools for next-generation sequencing
(NGS) preparation, and antibody libraries for drug discovery and
development. Twist is also pursuing longer-term opportunities in
digital data storage in DNA and biologics drug discovery. Twist
makes products for use across many industries including healthcare,
industrial chemicals, agriculture and academic research.
Legal Notice Regarding Forward-Looking Statements
This press release contains forward-looking statements. All
statements other than statements of historical facts contained
herein are forward-looking statements reflecting the current
beliefs and expectations of management made pursuant to the safe
harbor provisions of the Private Securities Litigation Reform Act
of 1995. Forward-looking statements involve known and unknown
risks, uncertainties, and other important factors that may cause
Twist Bioscience’s actual results, performance, or achievements to
be materially different from any future results, performance, or
achievements expressed or implied by the forward-looking
statements. For a description of the risks and uncertainties that
could cause actual results to differ from those expressed in these
forward-looking statements, as well as risks relating to Twist
Bioscience’s business in general, see Twist Bioscience’s risk
factors set forth in Twist Bioscience’s Quarterly Report Form 10-Q
filed with the Securities and Exchange Commission on February 9,
2022 and subsequent filings with the SEC. Any forward-looking
statements contained in this press release speak only as of the
date hereof, and Twist Bioscience specifically disclaims any
obligation to update any forward-looking statement, whether as a
result of new information, future events or otherwise.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220421005163/en/
Angela Bitting SVP, Corporate Affairs Twist Bioscience
abitting@twistbioscience.com
Twist Bioscience (NASDAQ:TWST)
Historical Stock Chart
From Jun 2024 to Jul 2024
Twist Bioscience (NASDAQ:TWST)
Historical Stock Chart
From Jul 2023 to Jul 2024